Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Viwit Baike Pharmaceutical is a core subsidiary of the Viwit Pharmaceutical Group, focusing on the development and large-scale production of high-end active pharmaceutical ingredients (APIs) and finished drug products. The company specializes in complex chemical synthesis, particularly in boron chemistry and chiral technology, and has established a robust presence in the peptide therapeutics market. Its manufacturing facilities are designed to meet international standards, including US FDA and Chinese GMP requirements, supporting both its internal product portfolio and its CDMO services. Viwit Baike's product range covers critical therapeutic areas such as oncology, cardiovascular health, and metabolic disorders, providing cost-effective generic alternatives and supporting innovative drug development. The company is recognized for its integrated R&D and production platform, which facilitates the rapid transition of drug candidates from laboratory to commercial scale.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 山东威智百科药业.